Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prevnar 13 Advisory Committee Review Moved Back To November

Sep 06 2011

• By The Pink Sheet Daily

Related Content

Pfizer Anticipates Prevnar 13 For Older Adults Will Get Advisory Review In September

Mar 31 2011

ACIP's Support Of FDA-Approved Prevnar 13 Creates Opportunity For Larger Market

Feb 24 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window